Comparison of Febuxostat and Allopurinol in the Treatment of Patients with Chronic Kidney Disease Stage 3∼5 with Hyperuricemia

OBJECTIVE: To compare the efficacy of febuxostat and allopurinol in the treatment of chronic kidney disease (CKD) at stages 3∼5 with hyperuricemia. METHODS: A total of 100 patients with stage 3 to 5 CKD with hyperuricemia in our hospital from July 2018 to December 2019 were selected and divided into...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Zhimin, Xu, Lei, Wan, Bo, Wang, Liping, Zhao, Chengzhi, Wu, Gang, Xie, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578913/
https://www.ncbi.nlm.nih.gov/pubmed/36267140
http://dx.doi.org/10.1155/2022/1177946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578913/
https://www.ncbi.nlm.nih.gov/pubmed/36267140
http://dx.doi.org/10.1155/2022/1177946

Ejemplares similares